To evaluate the prevalence and clinical outcomes using a one-step method versus a two-step method to screen gestational diabetes mellitus
- PMID: 23617557
- DOI: 10.3109/14767058.2013.799656
To evaluate the prevalence and clinical outcomes using a one-step method versus a two-step method to screen gestational diabetes mellitus
Abstract
Objective: The goal of this study is to compare the prevalence and clinical outcomes of a one-step with a two-step screening method, both of which are commonly used for the diagnosis of gestational diabetes mellitus (GDM).
Methods: Women who presented for GDM screening and who consented to participate in this study were randomized into two groups. The women in Group 1 (n = 386) were screened using a one-step method (2-h, 75 g oral glucose tolerance test (OGTT)) and in Group 2 (n = 400) by a two-step method (the 50 g glucose challenge test (GCT) followed by the 100 g OGTT). The pregnancies were then classified into three subgroups as follows: women who had negative 2-h 75 g OGTT results according to IADPSG criteria (IADPSG-negative), women with negative 50 g GCT results (GCT-negative) and women with positive 50 g GCT results but negative 3-h 100 g OGTT results according to C&C criteria (C&C-negative).
Results: The prevalence of GDM using the one-step and two-step methods was 14.5% and 6%, respectively. In adjusted multivariable regression models, women in the GCT-negative and the C&C-negative groups had greater risk of polyhydramnios than women in the IADPSG-negative group [adjusted prevalence risk ratios (aPR), 1.40; 95% confidence intervals (CI), 1.03-1.91; aPR, 2.76; 95% CI, 1.27-6.02, respectively]. Women in the C&C-negative group had greater risk of pre-eclampsia than women in the IADPSG-negative group (aPR, 3.30; 95% CI, 1.57-6.91).
Conclusions: Women who were defined as having normal glucose tolerance by IADPSG had better perinatal outcomes than women who were defined as having normal glucose tolerance by GCT and women who were GCT-positive with a negative OGTT.
Similar articles
-
Are women positive for the One Step but negative for the Two Step screening tests for gestational diabetes at higher risk for adverse outcomes?Acta Obstet Gynecol Scand. 2018 Feb;97(2):122-134. doi: 10.1111/aogs.13254. Epub 2017 Dec 12. Acta Obstet Gynecol Scand. 2018. PMID: 29091257 Review.
-
Application of One-Step IADPSG Versus Two-Step Diagnostic Criteria for Gestational Diabetes in the Real World: Impact on Health Services, Clinical Care, and Outcomes.Curr Diab Rep. 2017 Aug 10;17(10):85. doi: 10.1007/s11892-017-0922-z. Curr Diab Rep. 2017. PMID: 28799123 Free PMC article. Review.
-
The impact of adoption of the international association of diabetes in pregnancy study group criteria for the screening and diagnosis of gestational diabetes.Am J Obstet Gynecol. 2015 Feb;212(2):224.e1-9. doi: 10.1016/j.ajog.2014.08.027. Epub 2014 Aug 27. Am J Obstet Gynecol. 2015. PMID: 25173183
-
Are patients with positive screening but negative diagnostic test for gestational diabetes under risk for adverse pregnancy outcome?J Obstet Gynaecol Res. 2008 Jun;34(3):359-63. doi: 10.1111/j.1447-0756.2008.00788.x. J Obstet Gynaecol Res. 2008. PMID: 18588612
-
Prevalence of gestational diabetes mellitus (GDM) in women screened by glucose challenge test (GCT) at Maharaj Nakorn Chiang Mai Hospital.J Med Assoc Thai. 2004 Oct;87(10):1141-6. J Med Assoc Thai. 2004. PMID: 15560687
Cited by
-
Various screening and diagnosis approaches for gestational diabetes mellitus and adverse pregnancy outcomes: a secondary analysis of a randomized non-inferiority field trial.BMJ Open Diabetes Res Care. 2023 Dec 12;11(6):e003510. doi: 10.1136/bmjdrc-2023-003510. BMJ Open Diabetes Res Care. 2023. PMID: 38164706 Free PMC article. Clinical Trial.
-
Gestational Diabetes Mellitus Does Not Worsen Obstetrical and Neonatal Outcomes of Twin Pregnancy.J Clin Med. 2023 Apr 26;12(9):3129. doi: 10.3390/jcm12093129. J Clin Med. 2023. PMID: 37176571 Free PMC article.
-
One-step versus two-step screening for diagnosis of gestational diabetes mellitus in Iranian population: A randomized community trial.Front Endocrinol (Lausanne). 2023 Feb 2;13:1039643. doi: 10.3389/fendo.2022.1039643. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36818463 Free PMC article. Clinical Trial.
-
Perinatal Outcomes of Two Screening Strategies for Gestational Diabetes Mellitus: A Randomized Controlled Trial.Obstet Gynecol. 2021 Jul 1;138(1):6-15. doi: 10.1097/AOG.0000000000004431. Obstet Gynecol. 2021. PMID: 34259458 Free PMC article. Clinical Trial.
-
Screening for Gestational Diabetes during the COVID-19 Pandemic-Current Recommendations and Their Consequences.Medicina (Kaunas). 2021 Apr 15;57(4):381. doi: 10.3390/medicina57040381. Medicina (Kaunas). 2021. PMID: 33920937 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous